2 months Barrington Research Issues Pessimistic Forecast for Anika Therapeutics (NASDAQ:ANIK) Stock Price MarketBeat
Barrington Research dropped their price objective on Anika Therapeutics from $37.00 to $25.00 and set an “outperform” rating for the company in a report on Friday.
X